| Peer-Reviewed

Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review

Received: 14 May 2022    Accepted: 2 June 2022    Published: 14 June 2022
Views:       Downloads:
Abstract

Sarcomatoid carcinoma of the gallbladder is a highly malignant tumor originating from totipotent mesenchymal stem cells, accounting for only 4.1% of gallbladder cancers. Its clinical manifestations are very similar to adenocarcinoma of the gallbladder, mainly presenting in the digestive tract. Surgical resection is currently the only possible cure for sarcomatoid carcinoma of the gallbladder. Due to the lack of effective diagnostic means at early stage, many patients have reached the middle and late stage of diagnosis, and the prognosis is often poor. In this paper, we present a case of a 52-year-old woman with advanced and rapidly progressing sarcomatoid carcinoma of the gallbladder causing obstructive cholangitis. She developed bone marrow suppression after immunotherapy combined with chemotherapy. The patient died after symptomatic and supportive treatment. This paper reports the whole process of diagnosis and treatment in this case of gallbladder sarcomatoid carcinoma, thus carring out a discussion based on relevant literaturea and providing a reference for treatment.

Published in Cancer Research Journal (Volume 10, Issue 2)
DOI 10.11648/j.crj.20221002.13
Page(s) 34-37
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Sarcomatoid Carcinoma of the Gallbladder, Diagnosis, Treatment, Obstructive Cholangitis

References
[1] Shi Y, Chen J, Chen H, et al. Sarcomatoid carcinoma of the gallbladder: a case report. J Int Med Res. 2020, 48 (6): 300060520935283.
[2] Hamdani N H, Qadri S K, Aggarwalla R, et al. Clinicopathological study of gall bladder carcinoma with special reference to gallstones: our 8-year experience from eastern India [J]. Asian Pac J Cancer Prev, 2012, 13 (11): 5613-5617.
[3] Hundal R, Shaffer E A. Gallbladder cancer: epidemiology and outcome [J]. Clin Epidemiol, 2014, 6: 99-109.
[4] Siddiqui Mehdi, Hegde Sheetal, Nguyen Tung, et al. Sarcomatoid carcinoma of the gallbladder: A rare form of gallbladder cancer. SAGE open medical case reports. 2020, 8: 2050313X20906739.
[5] Song X, Hu Y, Li Y, et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 2020, 5 (1): 230.
[6] He Q Q. Clinicopathological and prognostic analysis of sarcomatoid carcinoma of digestive system [D]. Zhengzhou University Internal Medicine (Gastroenterology), 2017.
[7] Toledo PF, Berger Z, Carreño L, et al. Sarcomatoid carcinoma of the pancreas - a rare tumor with an uncommon presentation and course: A case report and review of literature. World J Clin Cases. 2021, 9 (15): 3716-3725.
[8] Li X P, Zhu C Y, Liu S L, et al. Diagnosis and treatment of sarcomatoid carcinoma of gallbladder: a report of 4 cases [J]. Hepatobiliary and pancreatic surgery, 2020, 32 (05): 307-309.
[9] Qin Q, Liu M, Wang X. Gallbladder sarcomatoid carcinoma: Seven case reports. World J Clin Cases. 2020, 8 (17): 3881-3889.
[10] Feng F, Cheng Q, Yang L, et al. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing [J]. Oncotarget, 2017, 8 (3): 5349-5360.
[11] Hu Z H, Li Z W, Shen L, et al. Surgical therapy and prognosis of sarcomatoid carcinoma of the gallbladder [J]. Hepatobiliary Pancreat Dis Int, 2010, 9 (2): 175-179.
[12] Zou W, Wolchok J D, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations [J]. Sci Transl Med, 2016, 8 (328): 324r-328r.
[13] Chamoto K, Al-Habsi M, Honjo T. Role of PD-1 in Immunity and Diseases [J]. Curr Top Microbiol Immunol, 2017, 410: 75-97.
[14] Sun L, Li CW, Chung EM, et al. Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. Cancer Res. 2020, 80 (11): 2298-2310.
[15] Song Z Q, Guo G F, Zhu Y M, et al. A case of super advanced sarcomatoid lung cancer induced by parbrizizumab [J]. Chin J Clin Lung, 2022, 27 (01): 150-153. 2022, 27 (01): 150-153.
[16] Bykov V J, Issaeva N, Shilov A, et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound [J]. Nat Med, 2002, 8 (3): 282-288.
[17] Deng M, Chen H H, Zhu X, et al. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China [J]. Int J Cancer, 2019, 145 (6): 1517-1528.
[18] Yi F. Clinical effect of ERCP in the treatment of acute obstructive suppurative cholangitis [J]. Contemporary medicine, 2021, 27 (32): 168-169.
[19] Ye Y, Huang R, Dai Y. Immunomodulatory effects of neutrophils in the state of homeostasis and pathology [J]. Journal of ling nan emergency medicine, 2020, 25 (03): 319-320.
Cite This Article
  • APA Style

    Ting Xiong, Shihua Liu, Yuying Lei, Liangliang Zhang, Aixia Sui. (2022). Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review. Cancer Research Journal, 10(2), 34-37. https://doi.org/10.11648/j.crj.20221002.13

    Copy | Download

    ACS Style

    Ting Xiong; Shihua Liu; Yuying Lei; Liangliang Zhang; Aixia Sui. Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review. Cancer Res. J. 2022, 10(2), 34-37. doi: 10.11648/j.crj.20221002.13

    Copy | Download

    AMA Style

    Ting Xiong, Shihua Liu, Yuying Lei, Liangliang Zhang, Aixia Sui. Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review. Cancer Res J. 2022;10(2):34-37. doi: 10.11648/j.crj.20221002.13

    Copy | Download

  • @article{10.11648/j.crj.20221002.13,
      author = {Ting Xiong and Shihua Liu and Yuying Lei and Liangliang Zhang and Aixia Sui},
      title = {Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review},
      journal = {Cancer Research Journal},
      volume = {10},
      number = {2},
      pages = {34-37},
      doi = {10.11648/j.crj.20221002.13},
      url = {https://doi.org/10.11648/j.crj.20221002.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20221002.13},
      abstract = {Sarcomatoid carcinoma of the gallbladder is a highly malignant tumor originating from totipotent mesenchymal stem cells, accounting for only 4.1% of gallbladder cancers. Its clinical manifestations are very similar to adenocarcinoma of the gallbladder, mainly presenting in the digestive tract. Surgical resection is currently the only possible cure for sarcomatoid carcinoma of the gallbladder. Due to the lack of effective diagnostic means at early stage, many patients have reached the middle and late stage of diagnosis, and the prognosis is often poor. In this paper, we present a case of a 52-year-old woman with advanced and rapidly progressing sarcomatoid carcinoma of the gallbladder causing obstructive cholangitis. She developed bone marrow suppression after immunotherapy combined with chemotherapy. The patient died after symptomatic and supportive treatment. This paper reports the whole process of diagnosis and treatment in this case of gallbladder sarcomatoid carcinoma, thus carring out a discussion based on relevant literaturea and providing a reference for treatment.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Sarcomatoid Carcinoma of the Gallbladder: A Case Report and Literature Review
    AU  - Ting Xiong
    AU  - Shihua Liu
    AU  - Yuying Lei
    AU  - Liangliang Zhang
    AU  - Aixia Sui
    Y1  - 2022/06/14
    PY  - 2022
    N1  - https://doi.org/10.11648/j.crj.20221002.13
    DO  - 10.11648/j.crj.20221002.13
    T2  - Cancer Research Journal
    JF  - Cancer Research Journal
    JO  - Cancer Research Journal
    SP  - 34
    EP  - 37
    PB  - Science Publishing Group
    SN  - 2330-8214
    UR  - https://doi.org/10.11648/j.crj.20221002.13
    AB  - Sarcomatoid carcinoma of the gallbladder is a highly malignant tumor originating from totipotent mesenchymal stem cells, accounting for only 4.1% of gallbladder cancers. Its clinical manifestations are very similar to adenocarcinoma of the gallbladder, mainly presenting in the digestive tract. Surgical resection is currently the only possible cure for sarcomatoid carcinoma of the gallbladder. Due to the lack of effective diagnostic means at early stage, many patients have reached the middle and late stage of diagnosis, and the prognosis is often poor. In this paper, we present a case of a 52-year-old woman with advanced and rapidly progressing sarcomatoid carcinoma of the gallbladder causing obstructive cholangitis. She developed bone marrow suppression after immunotherapy combined with chemotherapy. The patient died after symptomatic and supportive treatment. This paper reports the whole process of diagnosis and treatment in this case of gallbladder sarcomatoid carcinoma, thus carring out a discussion based on relevant literaturea and providing a reference for treatment.
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Hebei General Hospital, Shijiazhuang, China

  • Hebei General Hospital, Shijiazhuang, China

  • Hebei General Hospital, Shijiazhuang, China

  • Hebei General Hospital, Shijiazhuang, China

  • Hebei General Hospital, Shijiazhuang, China

  • Sections